BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8692777)

  • 1. [Inclusion body myositis].
    Serratrice G
    Presse Med; 1996 Jun; 25(21):985-8. PubMed ID: 8692777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
    Askanas V; Engel WK; Mirabella M
    Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New advances in the understanding of sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
    Askanas V; Engel WK
    Curr Opin Rheumatol; 1995 Nov; 7(6):486-96. PubMed ID: 8579968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy.
    Fidziańska A; Glinka Z
    Acta Neuropathol; 2006 Aug; 112(2):185-93. PubMed ID: 16788822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.
    Schmidt J; Barthel K; Zschüntzsch J; Muth IE; Swindle EJ; Hombach A; Sehmisch S; Wrede A; Lühder F; Gold R; Dalakas MC
    Brain; 2012 Apr; 135(Pt 4):1102-14. PubMed ID: 22436237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging.
    Askanas V; Engel WK
    Scand J Rheumatol; 1998; 27(6):389-405. PubMed ID: 9855208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New advances in inclusion-body myositis.
    Askanas V; Engel WK
    Curr Opin Rheumatol; 1993 Nov; 5(6):732-41. PubMed ID: 8117535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
    Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
    Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion body myositis in Alzheimer's disease.
    Roos PM; Vesterberg O; Nordberg M
    Acta Neurol Scand; 2011 Sep; 124(3):215-7. PubMed ID: 21824117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fourteen newly recognized proteins at the human neuromuscular junctions--and their nonjunctional accumulation in inclusion-body myositis.
    Askanas V; Engel WK; Alvarez RB
    Ann N Y Acad Sci; 1998 May; 841():28-56. PubMed ID: 9668220
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
    Askanas V; Engel WK; Nogalska A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers.
    Fratta P; Engel WK; Van Leeuwen FW; Hol EM; Vattemi G; Askanas V
    Neurology; 2004 Sep; 63(6):1114-7. PubMed ID: 15452314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau.
    Askanas V; Engel WK
    Presse Med; 2011 Apr; 40(4 Pt 2):e219-35. PubMed ID: 21392932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin Val122Ile, accumulated Abeta, and inclusion-body myositis aspects in cultured muscle.
    Askanas V; Engel WK; McFerrin J; Vattemi G
    Neurology; 2003 Jul; 61(2):257-60. PubMed ID: 12874414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E and alpha-1-antichymotrypsin polymorphisms in sporadic inclusion body myositis.
    Gossrau G; Gestrich B; Koch R; Wunderlich C; Schröder JM; Schroeder S; Reichmann H; Lampe JB
    Eur Neurol; 2004; 51(4):215-20. PubMed ID: 15159602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C and inclusion body myositis.
    Alexander JA; Huebner CJ
    Am J Gastroenterol; 1996 Sep; 91(9):1845-7. PubMed ID: 8792712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging.
    Askanas V; Engel WK
    Curr Opin Rheumatol; 2003 Nov; 15(6):737-44. PubMed ID: 14569203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.
    Kannanayakal TJ; Mendell JR; Kuret J
    Neurosci Lett; 2008 Jan; 431(2):141-5. PubMed ID: 18191026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
    Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
    Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two distinct forms of hyperphosphorylated tau in sporatic versus hereditary inclusion myopathy.
    Rosenblum WI
    J Neuropathol Exp Neurol; 1996 Nov; 55(11):1179-80. PubMed ID: 8939201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.